Chugai Pharmaceutical News

Chugai Pharmaceutical: Supplementary Materials for Consolidated Financial Statements for the Third Quarter of the Fiscal Year 2024.12 (IFRS)

Oct 25 04:00 ET

Chugai Pharmaceutical: Notice of Revisions to Dividend Forecast for Fiscal Year Ending December 31, 2024

Oct 25 04:00 ET

Chugai Pharmaceutical: Notice of Revisions to Financial Forecasts

Oct 25 04:00 ET

Chugai Pharmaceutical: CONSOLIDATED FINANCIAL STATEMENTS (IFRS) (Non-Audited)(for the third quarter of the fiscal year 2024)

Oct 25 04:00 ET

Chugai Pharmaceutical: F. Hoffmann-La Roche Announces Third Quarter Sales 2024

Oct 23 01:00 ET

Chugai Pharmaceutical: Sales results for the 3rd quarter of 2024 for F Hoffman La Roche

Oct 23 01:00 ET

Chugai Pharmaceutical: (Correction) Partial Correction to Consolidated Financial Statements (IFRS) for the 2023 Fiscal Year (Unaudited)

Jul 26 01:30 ET

Chugai Pharmaceutical: Provisional linked financial statements (IFRS) (unaudited) (Q2 of fiscal year 2024)

Jul 25 03:00 ET

Chugai Pharmaceutical: Supplemental materials for the interim consolidated financial statements for the second quarter of fiscal year 2024. (IFRS 12)

Jul 25 03:00 ET

Chugai Pharmaceutical: F. Hoffmann-La Roche announces half-year results for 2024.

Jul 25 01:00 ET

Chugai Pharmaceutical: Notice Concerning Completion of Disposal of Own Shares as a Stock Remuneration System with Transfer Restrictions

Apr 25 23:00 ET

Chugai Pharmaceutical: Supplementary material on consolidated financial results for the 1st quarter of fiscal year 2024. 12 (IFRS)

Apr 24 04:00 ET

Chugai Pharmaceutical: Consolidated Financial Statements (IFRS) (non-audited) (1st quarter of fiscal year 2024)

Apr 24 04:00 ET

Chugai Pharmaceutical: F. Hoffman La Roche announces sales for the first quarter of 2024

Apr 24 01:00 ET

Chugai Pharmaceutical: Sales results for F Hoffman La Roche for the first quarter of 2024

Apr 24 01:00 ET

Chugai Pharmaceutical: Corporate Governance Report

Mar 31 21:45 ET

Chugai Pharmaceutical: Matters relating to controlling shareholders, etc.

Mar 29 03:00 ET

Chugai Pharmaceutical: Notice of Disposal of Treasury Shares as Restricted Stock Compensation Plan

Mar 28 04:00 ET

Chugai Pharmaceutical: Independent Officer Notification Form

Mar 12 07:01 ET

Chugai Pharmaceutical: Eli Lilly & Co. Discloses Form 10-K containing Orforgripron-related information

Feb 21 18:30 ET